2William L. McGuire,Martin D. Abeloff,Gabriel N. Hortobagyi,Sandra M. Swain. Treatment of stage III breast cancer[J] 1989,Breast Cancer Research and Treatment(3):225～235
3Deborah K. Armstrong,John H. Fetting,Nancy E. Davidson,Gary B. Gordon,Ann Marie Huelskamp,Martin D. Abeloff. Sixteen week dose intense chemotherapy for inoperable, locally advanced breast cancer[J] 1993,Breast Cancer Research and Treatment(3):277～284
3Chollet P, Amat S, Cure H, et al. Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer[ J]. Br J Cancer,2002,86 (7) :1041 -1046.
4Lau GI, Loo WT, Chow LW. Neoadjuvant chemotherapy for breast cancer determined by chemosensitivity assay achieves better tumor responseⅢ Biomed Pharmacother,2007,61 (9) :562 - 565.
5Bear HD, Anderson S, Brown A, et al. The effect on tumor response of adding sequential preoperative decetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B -27 [ J ]. J Clin Oncol,2003,21 ( 11 ) :4165 - 4174.
6Schwartz GF, Mehzer A J, Lucareclli EA, et al. Breast conservation after neoadjuvant chemotherapy for stage II carcinoma of the breast [ J]. J Am Coil Surg,2005,201 (3) :327 - 334.
7Cleator SJ,Makfis A,Ashley SE,et aL Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival [ J ]. Ann Oncol,2005,16 ( 2 ) :267 - 272.
8Cleator SJ,MakrisA,Ashley SE,et al.Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associatedwith improved overall survival[J].Ann Oncol,2005,16:267-272.
9Early Breast Cancer Trialists'Collaborative Group(EBC-TCG).Effects of chemotherapy and hormonal therapy for early breastcancer on recurrence and 15-year survival:an overview of the ran-domised trials[J].Lancet,2005,365:1687-1717.
